SCHEMBL7672302

SCHEMBL7672302

O=C(O)CNS(=O)(=O)c1ccc(NC(=O)c2ccc3ccccc3c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 1/20 0.72
NR1H4 Q96RI1 1/20 0.62
ENPP3 O14638 2/20 0.60
ENPP1 P22413 2/20 0.60
ENPP2 Q13822 2/20 0.60
MMP2 P08253 1/20 0.60
MMP14 P50281 1/20 0.60
DEGS1 O15121 1/20 0.58
LMNA P02545 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
ALDH1A1 P00352 1/20 0.56
KAT6A Q92794 1/20 0.55
NPC1 O15118 1/20 0.54
CASP3 P42574 1/20 0.54
RAB9A P51151 1/20 0.54
SENP7 Q9BQF6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673748 0.86 ALDH1A1 (0.74) LMNAMEN1KMT2AALDH1A1
SCHEMBL4834530 0.86 LMNA (0.74) LMNAMEN1KMT2AALDH1A1
SCHEMBL7673888 0.84 LMNA (0.57) GPR27MMP2MMP14LMNAMEN1
SCHEMBL7675074 0.84 MMP1 (0.74) NR1H4MMP2MMP14LMNAMEN1
SCHEMBL24125071 0.84 GPR27 (1.00) GPR27NR1H4ENPP3ENPP1ENPP2
SCHEMBL7663141 0.83 GPR27 (0.59) GPR27NR1H4ENPP3ENPP1ENPP2
SCHEMBL14534186 0.82 MMP1 (0.71) MMP2MMP14LMNAMEN1KMT2A
SCHEMBL7665894 0.82 LMNA (0.60) LMNAMEN1KMT2AALDH1A1
SCHEMBL6438335 0.81 ALDH1A1 (0.69) KMT2AALDH1A1KAT6A
SCHEMBL7671620 0.81 LMNA (0.59) DEGS1LMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed